| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate |
1995-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7b67922ee7820c19e6bb66a9dce02f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9dc5348efb6f9885d9f9a5beaaad30b |
| publicationDate |
1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5681593-A |
| titleOfInvention |
Method and composition for treating psoriasis, seborrheic dermatitis and eczema |
| abstract |
Psoriasis, seborrheic dermatitis and eczema are treated by oral administration of inorganic nickel compound(s), with or without inorganic bromide(s). In an especially preferred embodiment, the nickel compound used to treat these diseases is NiBr 2 . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6613800-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6427022-B1 |
| priorityDate |
1990-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |